The following picks should outperform the market by a wide margin. Please do your own DD
Time to pick up all those bargains from the correction. The correction is
over in my opinion, and we could see the Nasdaq move up 400-600 points this
week. Linux should heat up again.
CYBR-15.25
This company is emerging as the leader in Telehealtcare. The industry is
valued at $25 billion, and an annual growth rate of %40. Watch CYBR become
the AOL of healthcare. CYBR should move rather substantially over the next
few weeks. The technicals are aligning for an even more powerfull rally than
Feb. Get it while it is under $20. FDA approval in next few days. I'm
holding this one for many years to come.
1 year target=$150 7-10 year target=$1000
ISLD-$34.88
ISLD is in the market to help business's globalize their market. Revenues and
customer base is on the rise. Technicals looking very good. Closed above the
13 day EMA, MACD histogram positive, and MACD is making its way to the
positive. Short interest was very high for past month, watch the shorts
scramble for cover when the market starts moving back up.
2 month target $60
JMAR-$5.94
JMAR has converted from the hardware to semiconductor market. Semiconductor
sales are looking very good, and has a couple exciting new chips out by the
end of the year. Look into the new FIFO chip. Targeting the
telecommunications equipment market, and biotechnology industry. Blossoming
company with huge growth ahead of it. I think it has found its home in the $6
range. The semiconductor sector is heating up again, and is forecasted to
grow another %400 this year. Technicals are looking better. MACD histogram
just went positive, and the MACD is turning up again.
3 month target $10 1 year target $25
SSFT-$3.28
SSFT makes optical character recognition software, and varies other
software's. SSFT was spun off by Xerox a few years back. SSFT recently was
added to Microsoft's Frontpage 2000 software package. SSFT niche will be
getting corporate document's digitized to reduce paper use and storage. Very
undervalued currently, and has shown it can move on news. Technicals are not
looking all that hot right now. Looking for a recovery of share price soon.
3 month target $6 1 year target $10
